DE MANZONI, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 6.992
NA - Nord America 6.953
AS - Asia 3.951
SA - Sud America 367
AF - Africa 103
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 18.400
Nazione #
US - Stati Uniti d'America 6.901
GB - Regno Unito 2.568
CN - Cina 1.885
SG - Singapore 1.564
IT - Italia 794
RU - Federazione Russa 684
SE - Svezia 608
IE - Irlanda 570
FR - Francia 554
DE - Germania 451
FI - Finlandia 394
BR - Brasile 325
UA - Ucraina 149
KR - Corea 92
TR - Turchia 90
HK - Hong Kong 88
JP - Giappone 59
NL - Olanda 51
TG - Togo 48
BE - Belgio 38
AT - Austria 37
VN - Vietnam 33
CA - Canada 31
RW - Ruanda 21
AU - Australia 20
CZ - Repubblica Ceca 16
IR - Iran 13
MX - Messico 13
IL - Israele 12
AE - Emirati Arabi Uniti 11
UZ - Uzbekistan 11
ID - Indonesia 10
IN - India 10
KG - Kirghizistan 10
EU - Europa 9
EC - Ecuador 8
NO - Norvegia 8
PK - Pakistan 8
AR - Argentina 7
IQ - Iraq 7
LV - Lettonia 7
PT - Portogallo 7
BD - Bangladesh 6
ES - Italia 6
MA - Marocco 6
PL - Polonia 6
CL - Cile 5
PH - Filippine 5
TW - Taiwan 5
UY - Uruguay 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
EG - Egitto 4
JO - Giordania 4
KE - Kenya 4
LT - Lituania 4
PE - Perù 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
AL - Albania 3
GR - Grecia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MK - Macedonia 3
PA - Panama 3
PY - Paraguay 3
SI - Slovenia 3
AM - Armenia 2
AO - Angola 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GY - Guiana 1
Totale 18.391
Città #
Southend 2.395
Jacksonville 1.152
Chandler 1.142
Singapore 938
Woodbridge 698
Dublin 565
Ann Arbor 459
Verona 352
Ashburn 336
Beijing 317
Houston 306
Lawrence 204
Princeton 204
Wilmington 199
Jinan 180
New York 164
Nanjing 154
Shenyang 139
Redmond 132
Hebei 100
Sindelfingen 97
Helsinki 95
Milan 93
The Dalles 91
Hong Kong 87
Changsha 66
Nanchang 61
Tianjin 59
Haikou 56
Seoul 56
Zhengzhou 54
Los Angeles 52
Tokyo 52
Lomé 48
Jiaxing 47
Ningbo 47
Guangzhou 43
Seattle 43
Boardman 42
Taizhou 39
Brussels 38
Santa Clara 33
Amsterdam 31
Dallas 31
Hangzhou 31
Dearborn 30
Moscow 29
Norwalk 28
Nuremberg 26
Vienna 26
São Paulo 22
Dong Ket 21
Fuzhou 21
Kigali 21
Redwood City 21
Taiyuan 21
Lanzhou 20
Rome 20
Falls Church 18
Washington 18
San Francisco 16
Fairfield 15
Lappeenranta 14
Rio de Janeiro 14
Toronto 14
Council Bluffs 13
Dongguan 12
Lancaster 12
Chicago 11
London 11
Auburn Hills 10
Curitiba 10
Florence 10
Jakarta 10
Kent 10
Ottawa 10
Tashkent 10
Belo Horizonte 9
Bishkek 9
Detroit 9
Brescia 8
Frankfurt am Main 8
Padova 8
Paris 8
Storo 8
Tombolo 8
Adelaide 7
Bedford 7
Columbus 7
Fredrikstad 7
Goiânia 7
San Diego 7
Ankara 6
Brno 6
Dubai 6
Düsseldorf 6
Edinburgh 6
Erba 6
Kemerovo 6
Renton 6
Totale 12.237
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 215
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 194
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 162
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 149
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 148
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 137
Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years 137
Genomic characterization of hepatoid tumors: context matters 135
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 128
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 128
Adenocarcinoma of the esophagogastric junction 128
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 127
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 122
Emergency sclerotherapy in esophageal and gastric acutely variceal bleeding : ten years expérience (1988-1997). 119
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 117
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 116
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 114
Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction 112
Via biliare principale, pancreatite acuta e chirurgia mini-invasiva. 112
Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases 112
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 112
Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study 111
Valutazione di uno screening colonscopico in pazienti ad alto rischio di CRC 111
Acute hemorrhage secondary to gastric ulcer. Results of emergency endoscopic treatment in 775 cases. 111
Valutazione dell’applicabilità del modello organizzativo della weeksurgery alle Chirurgia Generale di un Presidio di un’AziendaOspedaliera del Veneto 108
Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. 107
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. 107
Enhanced recovery protocol in esophagectomy, is it really worth it? A cost analysis related to team experience and protocol compliance 106
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 104
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? 103
The value of in vitro ultrasonography in the intraoperative staging of gastric cancer. Blind study of 93 cases. 103
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 103
Experience on complex incisional hernia treatment in septic patients 102
Number of lymph node metastases and its prognostic significance in early gastric cancer: A multicenter italian. study. 101
Perigastric lymph node metastasis in gastric cancer: comparison between different staging systems 101
Changing clinical and pathological features of gastric cancer over time. 101
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 101
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 100
hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. 100
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 100
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 100
Endoscopic submucosal dissection in the treatment of gastric submucosal tumors: results from a retrospective cohort study. 99
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience 99
Authors' reply: Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci (letter) 98
Endosonography in esophageal cancer staging after preoperative chemo and radiotherapy. 98
Short-term and long-term risk factors in gastric cancer 97
Emergency cholecystostomy and subsequent cholecystectomy for acute gallstone cholecystitis in the elderly. 96
Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging (letter) 96
Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus:impact of increased dosage on long-term results 96
Il Trattamento dei tumori del rene associati ad aneurismi dell’aorta addominale. 96
Induction chemio-radiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase 2 study 95
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 95
Surgical treatment of abdominal aortic aneurysm with concomitant renal cell carcinoma: a single-centre experience with review of the literature. 95
Western strategy for EGJ carcinoma 95
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 95
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 95
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 94
Nodal Staging in Adenocarcinoma of the Gastro-Esophageal Junction. Proposal of a Specific Staging System. Ann Surg Oncol. 94
Staging and treatment of gastric cancer 94
[Advanced gastric adenocarcinoma with RER+ phenotype presents a good prognosis after 5 years of curative resection] 94
Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre 93
hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett’s esophagus 93
Using the angio-seal to achieve hemostasis in prosthetic endovascular surgery: report of three cases. 93
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 93
Factors influencing survival after hepatectomy for metastases from gastric cancer 93
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 92
Lymphadenectomy for gastric cancer at European specialist centres 92
Lymphatic spread, lymph node stations, and levels of lymphatic dissection in gastric cancer 91
Para-aortic lymph node involvement in gastric adenocarcinoma. 90
Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer 90
Is the Goseki histological grading of gastric cancer a new prognostic factors? 90
Late events and clinical prognostic factors in stage 1 non small cell lung cancer 89
Perianal Paget's disease: presentation of six cases and literature review. 89
Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer. 88
Super-extended (D3) lymphadenectomy in advanced gastric cancer . 88
Proximal Gastrectomy: Technical Notes 88
Clinical pathways in gastric cancer care 88
Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG) 88
Lymphadenectomy: how to do it? 87
Laminin receptor expression in advanced gastric cancer 85
Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction 85
Clinical significance of mutator phenotype and chromosomes 17p and 18q allelic loss in gastric cancer 85
Prognostic Value of the 7th AJCC/UICC TNM Classification of Noncardia Gastric Cancer: Analysis of a Large Series From Specialized Western Centers. 85
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 84
La stadiazione del carcinoma dell'esofago dopo tratamento neoadiuvante pre-operatorio. 84
Risk Assessment and prediction of rebleeding in bleeding gastroduodenal ulcer 83
The role of resistin in colorectal cancer. 83
Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma. 82
Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum 82
Laparoscopic approach to postoperative adhesive obstruction 82
Iatrogenic axillary artery injury from humeral neck fracture repair. A rare and unusual event in which and aggressive strategy was mandatory to save a child limb 82
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 82
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 82
Complications after gastrectomy for cancer: Italian perspective 82
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 82
Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer (letter) 81
Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery 81
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 81
Lack of an association between circulating adiponectin levels and risk of colorectal adenoma. 81
Epidemiology of gastric cancer and screening programs 81
Totale 10.175
Categoria #
all - tutte 73.527
article - articoli 65.445
book - libri 1.039
conference - conferenze 4.214
curatela - curatele 0
other - altro 419
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.410
Totale 147.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020547 0 0 0 0 0 0 0 0 0 192 100 255
2020/20211.868 243 332 74 180 197 195 42 120 123 95 208 59
2021/20221.520 93 382 37 129 83 39 40 111 53 53 121 379
2022/20233.544 242 310 327 622 297 867 14 255 384 27 88 111
2023/20242.015 58 167 170 254 219 321 108 110 25 121 351 111
2024/20253.814 295 333 273 846 267 183 400 291 747 179 0 0
Totale 18.711